Venture Valuation Launches Redesigned Website with Enhanced User Experience

ZURICH, SWITZERLAND – February 26, 2026 – Venture Valuation, a leading independent provider of valuation services for the global life sciences industry, today announced the launch of its newly redesigned website at VentureValuation.com.

The new site features a completely modernized and cleaner design, significantly improving the user interface and overall user experience. The update reflects Venture Valuation’s commitment to providing its clients in the biotech, pharma and medtech sectors with the most efficient and accessible digital touchpoint.

The redesigned website makes it easier for visitors to navigate the company’s comprehensive range of services, including company and product valuations, investor services and access to its industry-leading Biotechgate database. Client testimonials, showcasing over 25 years of experience and trusted partnerships with industry leaders, are prominently featured, offering immediate social proof of the company’s expertise.

“Our goal with this redesign was to create a digital environment that matches the clarity, precision and forward-thinking approach we bring to our valuation work,” said Patrik Frei, CEO of Venture Valuation. “We believe a cleaner and more modern online presence will allow our clients and partners to more intuitively explore how we can support them in their critical business development and licensing decisions.”

Visitors to the new site are encouraged to explore the enhanced layout and discover how Venture Valuation’s tailored services can help them understand the true value of their life science assets.

About Venture Valuation
Venture Valuation is an independent firm specializing in the valuation of companies, products, and technologies within the global life sciences sector. For over 25 years, the company has supported entrepreneurs, investors, and pharmaceutical companies with unbiased assessments, helping them navigate negotiations, licensing deals, and strategic growth. Venture Valuation is also the provider of the Biotechgate database and the Biotechgate Digital Partnering conference.